Rett syndrome: the complex nature of a monogenic disease (original) (raw)

References

  1. Shahbazian M, Zoghbi H (2002) Rett syndrome and MeCP2: linking epigenetics and neuronal function. Am J Hum Genet 71:1259–1272
    Article CAS PubMed Google Scholar
  2. Trevathan E, Moser HW (1988) Diagnostic criteria for Rett syndrome. Ann Neurol 23:425–428
    PubMed Google Scholar
  3. Skjeldal OH, von Tetzchner S, Jacobsen K, Smith L (1995) Rett syndrome-distribution of phenotypes with special attention to the preserved speech variant. Neuropediatrics 26:87
    CAS PubMed Google Scholar
  4. Zappella M (1994) Rett syndrome-like hand washing, developmental arrest and autistic symptoms in two Italian girls. Eur Child Adolesc Psychiatry 3:52–56
    Google Scholar
  5. Zappella M (1997) The preserved speech variant of the Rett complex: a report of 8 cases. Eur Child Adolesc Psychiatry 6:23–25
    PubMed Google Scholar
  6. Zappella M, Gillberg C, Ehlers S (1998) The preserved speech variant: a subgroup of the Rett complex: a clinical report of 30 cases. J Autism Dev Disord 28:519–526
    CAS PubMed Google Scholar
  7. Zappella M (1992) The Rett girls with preserved speech. Brain Dev 14:98–101
    Google Scholar
  8. Zappella M, Meloni I, Longo I, Canitano R, Hayek G, Rosaia L, Mari F, Renieri A (2003) Study of MECP2 gene in Rett syndrome variants and autistic girls. Am J Med Genet 10.1002/ajmg.b.10070
  9. Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY (1999) Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 23:185–188
    CAS PubMed Google Scholar
  10. Huppke P, Laccone F, Kramer N, Engel W, Hanefeld F (2000) Rett syndrome: analysis of MECP2 and clinical characterization of 31 patients. Hum Mol Genet 9:1369–1375
    Google Scholar
  11. Wan M, Lee SS, Zhang X, Houwink-Manville I, Song HR, Amir RE, Budden S, Naidu S, Pereira JL, Lo IF, Zoghbi HY, Schanen NC, Francke U (1999) Rett syndrome and beyond: recurrent spontaneous and familial MECP2 mutations at CpG hotspots. Am J Hum Genet 65:1520–1529
    CAS PubMed Google Scholar
  12. Trappe R, Laccone F, Colibanschi J, Meins M, Huppke P, Hanefeld F, Engel W (2001) MECP2 mutations in sporadic cases of Rett syndrome are almost exclusively of paternal origin. Am J Hum Genet 68:1093–1101
    CAS PubMed Google Scholar
  13. Girard M, Couvert P, Carrié A, Tardieu M, Chelly J, Beldjord C, Bienvenu T (2001) Parental origin of de novo MECP2 mutations in Rett syndrome. Eur J Hum Genet 9:231–236
    Article CAS PubMed Google Scholar
  14. Bienvenu T, Carrie A, de Roux N, Vinet MC, Jonveaux P, Couvert P, Villard L, Arzimanoglou A, Beldjord C, Fontes M, Tardieu M, Chelly J (2000) MECP2 mutations account for most cases of typical forms of Rett syndrome. Hum Mol Genet 9:1377–1384
    Google Scholar
  15. Cheadle J, Gill H, Fleming N, Maynard J, Kerr A, Leonard H, Krawczak M, Cooper DN, Lynch S, Thomas N, Hughes H, Hulten M, Ravine D, Sampson JR, Clarke A (2000) Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: correlation of disease severity with mutation type and location. Hum Mol Genet 9:1119–1129
    Google Scholar
  16. De Bona C, Zappella M, Hayek G, Meloni I, Vitelli F, Bruttini M, Cusano R, Loffredo P, Longo I, Renieri A (2000) Preserved speech variant is allelic of classic Rett syndrome. Eur J Hum Genet 8:325–330
    PubMed Google Scholar
  17. Laccone F, Huppke P, Hanefeld F, Meins M (2001) Mutation spectrum in patients with Rett syndrome in the German population: evidence of hot spot regions. Hum Mutat 17:183–190
    Article CAS PubMed Google Scholar
  18. Nielsen JB, Henriksen KF, Hansen C, Silahtaroglu A, Schwartz M, Tommerup N (2001) MECP2 mutations in Danish patients with Rett syndrome: high frequency of mutations but no consistent correlations with clinical severity or with the X chromosome inactivation pattern. Eur J Hum Genet 9:178–184
    Article CAS PubMed Google Scholar
  19. Zappella M, Meloni I, Longo I, Hayek G, Renieri A (2001) Preserved speech variants of the Rett syndrome: molecular and clinical analysis. Am J Med Genet 104:14–22
    CAS PubMed Google Scholar
  20. Clayton-Smith J, Watson P, Ramsden S, Black GC (2000) Somatic mutation in MECP2 as a non-fatal neurodevelopmental disorder in males. Lancet 356:830–832
    Article CAS PubMed Google Scholar
  21. Topcu M, Akyerli C, Sayi A, Toruner A, Kocoglu SR, Cimbis M, Ozcelik T (2002) Somatic mosaicism for a MECP2 mutation associated with classic Rett syndrome in a boy. Eur J Hum Genet 10:77–81
    Article CAS PubMed Google Scholar
  22. Villard L, Cardoso AK, Chelly PJ, Tardieu PM, Fontes M (2000) Two affected boys in a Rett syndrome family: clinical and molecular findings. Neurology 55:1188–1193
    CAS PubMed Google Scholar
  23. Meloni I, Bruttini M, Longo I, Mari F, Rizzolio F, D'Adamo P, Denvriendt K, Fryns J-P, Toniolo D, Renieri A (2000) A mutation in the Rett syndrome gene, MECP2, causes X-linked mental retardation and progressive spasticity in males. Am J Hum Genet 67:982–985
    Google Scholar
  24. Couvert P, Bienvenu T, Aquaviva C, Poirier K, Moraine C, Gendrot C, Verloes A, Andres C, Le Fevre AC, Souville I, Steffann J, des Portes V, Ropers HH, Yntema HG, Fryns JP, Briault S, Chelly J, Cherif B (2001) MECP2 is highly mutated in X-linked mental retardation. Hum Mol Genet 10:941–946
    Google Scholar
  25. Yntema H, Oudakker A, Kleefstra T, Hamel B, van Bokhoven H, Chelly J, Kalscheuer V, Fryns J, Raynaud M, Moizard M, Moraine C (2002) In-frame deletion in MECP2 causes mild nonspecific mental retardation. Am J Med Genet 107:81–83
    PubMed Google Scholar
  26. Winnepenninckx B, Errijgers V, Hayez-Delatte F, Reyniers E, Frank Kooy R (2002) Identification of a family with nonspecific mental retardation (MRX79) with the A140 V mutation in the MECP2 gene: is there a need for routine screening? Hum Mutat 20:249–252
    Google Scholar
  27. D'Esposito M, Quaderi NA, Ciccodicola A, Bruni P, Esposito T, D'Urso M, Brown SDM (1996) Isolation, physical mapping, and Northern analysis of the X-linked human gene encoding methyl CpG-binding protein, MECP2. Mammal Genome 7:533–535
    CAS Google Scholar
  28. Jones PL, Veenstra GJ, Wade PA, Vermaak D, Kass SU, Landsberger N, Strouboulis J, Wolffe AP (1998) Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet 19:187–191
    CAS PubMed Google Scholar
  29. Kokura K, Kaul S, Wadhwa R, Nomura T, Khan M, Shinagawa T, Yasukawa T, Colmenares C, Ishii S (2001) The Ski protein family is required for MeCP2-mediated transcriptional repression. J Biol Chem 276:34115–34121
    Article CAS PubMed Google Scholar
  30. Kaludov NK, Wolffe AP (2000) MeCP2 driven transcriptional repression in vito: selectivity for methylated DNA, action at a distance and contacts with the basal transcription machinery. Nucleic Acids Res 28:1921–1928
    CAS PubMed Google Scholar
  31. Yusufzai TM, Wolffe AP (2000) Functional consequences of Rett syndrome mutations on human MeCP2. Nucleic Acids Res 28:4172–4179
    Article CAS PubMed Google Scholar
  32. Colvin L, Fyfe S, Leonard S, Schiavello T, Ellaway C, De Klerk N, Christodoulou J, Msall M, Leonard H (2003) Describing the phenotype in Rett syndrome using a population database. Arch Dis Child 88:38–43
    Article CAS PubMed Google Scholar
  33. Amir RE, Van den Veyver IB, Schultz R, Malicki DM, Tran CQ, Dahle EJ, Philippi A, Timar L, Percy AK, Motil KJ, Lichtarge O, Smith EO, Glaze DG, Zoghbi HY (2000) Influence of mutation type and X chromosome inactivation on Rett syndrome phenotypes. Ann Neurol 47:670–679
    CAS PubMed Google Scholar
  34. Monros E, Armstrong J, Aibar E, Poo P, Canos I, Pineda M (2001) Rett syndrome in Spain: mutation analysis and clinical correlations. Brain Dev [Suppl 1]:S251–S253
  35. Huppke P, Held M, Hanefeld F, Engel W, Laccone F (2002) Influence of mutation type and location on phenotype in 123 patients with Rett syndrome. Neuropediatrics 33:105–108
    Article CAS PubMed Google Scholar
  36. Imessaoudene B, Bonnefont J, Royer G, Cormier-Daire V, Lyonnet S, Lyon G, Munnich A, Amiel J (2001) MECP2 mutation in non-fatal, non-progressive encephalopathy in a male. J Med Genet 38:171–174
    Article CAS PubMed Google Scholar
  37. Orrico A, Lam, C-W, Galli L, Dotti MT, Hayek G, Tong SF, Poon, PMK, Zappella M, Federico A, Sorrentino V (2000) MECP2 mutation in male with non-specific X-linked mental retardation. FEBS Lett 24106:1–4
    Google Scholar
  38. Cohen D, Lazar G, Couvert P, Desportes V, Lippe D, Mazet P, Heron D (2002) MECP2 mutation in a boy with language disorder and schizophrenia. Am J Psychiatry 159:149–149
    Article PubMed Google Scholar
  39. Moncla A, Kpebe A, Missirian C, Mancini J, Villard L (2002) Polymorphisms in the C-terminal domain of MECP2 in mentally handicapped boys: implications for genetic counseling. Eur J Hum Genet 10:86–89
    CAS PubMed Google Scholar
  40. Yntema HG, Kleefstra T, Oudakker AR, de Vries, et al. (2002) Low frequency of MECP2 mutations in mental retardation of unknown origin: implications for routine DNA diagnostics. Nature, Strasbourg
    Google Scholar
  41. Laccone F, Zoll B, Huppke P, Hanefeld F, Pepinski W, Trappe R (2002) MECP2 gene nucleotide changes and their pathogenicity in males: proceed with caution. J Med Genet 39:586–588
    Article CAS PubMed Google Scholar
  42. Ishii T, Makita Y, Ogawa A, Amamiya S, Yamamoto M, Miyamoto A, Oki J (2001) The role of different X-inactivation pattern on the variable clinical phenotype with Rett syndrome. Brain Dev [Suppl 1]:S161–S164
  43. Sharp A, Robinson D, Jacobs P (2000) Age- and tissue-specific variation of X chromosome inactivation ratios in normal women. Hum Genet 107:343–349
    CAS PubMed Google Scholar
  44. Zoghbi HY, Percy AK, Schultz RJ, Fill C (1990) Patterns of X chromosome inactivation in the Rett syndrome. Brain Dev 12:131–135
    CAS PubMed Google Scholar
  45. Shahbazian MD, Sun Y, Zoghbi HY (2002) Balanced X chromosome inactivation patterns in the Rett syndrome brain. Am J Med Genet 111:164–168
    Article PubMed Google Scholar
  46. LaSalle JM, Goldstine J, Balmer D, Greco CM (2001) Quantitative localization of heterogeneous methyl-CpG-binding protein 2 (MeCP2) expression phenotypes in normal and Rett syndrome brain by laser scanning cytometry. Hum Mol Genet 10:1729–1740
    CAS PubMed Google Scholar
  47. Yntema H, Kleefstra T, Oudakker A, de Vries B, Nillesen W, Sistermans E, Brunner H, Hamel B, van Bokhoven H (2002) Low frequency of MECP2 mutations in mental retardation of unknown origin: implications for routine DNA diagnostics. Nature, Strasbourg
    Google Scholar
  48. Sirianni N, Naidu S, Pereira J, Pillotto R, Hoffman E (1998) Rett syndrome: confirmation of X-linked dominant inheritance, and localization of the gene to Xq28. Am J Hum Genet 63:1552–1558
    CAS PubMed Google Scholar
  49. Schollen E, Deflem E, Smeets E, Fryns J, Matthijs G (2002) Gross rearrangements in the MECP2 gene in two patients with Rett syndrome. University of Chicago Press, Baltimore
  50. Villard L, Levy N, Xiang F, Kpebe A, Labelle V, Chevillard C, Zhang Z, Schwartz C, Tardieu M, Chelly J, Anvret M, Fontes M (2001) Segregation of a totally skewed pattern of X chromosome inactivation in four familial cases of Rett syndrome without MECP2 mutation: implications for the disease. J Med Genet 38:435–442
    Article CAS PubMed Google Scholar
  51. Delobel B, Delannoy V, Pini G, Zapella M, Tardieu M, Vallée L, Croquette MF (1998) Identification and molecular characterization of a small 11q23.3 de novo duplication in a patient with Rett syndrome manifestations. Am J Med Genet 80:273–280
    Article CAS PubMed Google Scholar
  52. Gordon K, Siu Mok V, Sergovich F, Jung J (1993) 18q-mosaicism associated with Rett syndrome phenotype. Am J Med Genet 46:142–144
    CAS PubMed Google Scholar
  53. Gustavsson P, Kimber E, Wahlstrom J, Annerén G (1999) Monosomy 18q syndrome and atypical Rett syndrome in a girl with an interstitial deletion (18)(q21.1q22.3). Am J Med Genet 82:348–351
    Google Scholar
  54. Wahlstrom J, Uller A, Johannesson T, Holmqvist D, Darnfors C, Vujic M, Tonnby B, Hagberg B, Martinsson T (1999) Congenital variant Rett syndrome in a girl with terminal deletion of chromosome 3p. J Med Genet 36:343–345
    CAS PubMed Google Scholar
  55. Simonic I, Gericke GS, Lippert M, Schoeman JF (1997) Additional clinical and cytogenetic findings associated with Rett syndrome. Am J Med Genet 74:331–337
    CAS PubMed Google Scholar
  56. Journel H, Melki J, Turleau C, Munnich A, de Grouchy J (1990) Rett phenotype with X/autosome translocation: possible mapping to the short arm of chromosome X. Am J Med Genet 35:142–147
    CAS PubMed Google Scholar
  57. Zoghbi HY, Ledbetter D, Schultz R, Percy A, Glaze D (1990) A de novo X;3 translocation in Rett syndrome. Am J Med Genet 35:148–151
    CAS PubMed Google Scholar
  58. Balmer D, Goldstine J, Rao YM, LaSalle JM (2003) Elevated methyl-CpG-binding protein 2 expression is acquired during postnatal human brain development and is correlated with alternative polyadenylation. J Mol Med 81:61–68
    CAS PubMed Google Scholar
  59. Chen RZ, Akbarian S, Tudor M, Jaenisch R (2001) Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat Genet 27:327–331
    Google Scholar
  60. Guy J, Hendrich B, Holmes M, Martin JE, Bird A (2001) A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet 27:322–326
    Google Scholar
  61. Shahbazian M, Young J, Yuva-Paylor L, Spencer C, Antalffy B, Noebels J, Armstrong D, Paylor R, Zoghbi H (2002) Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron 35:234–254
    Google Scholar
  62. Ng H, Zhang Y, Hendrich B, Johnson C, Turner B, Erdjument-Bromage H, Tempst P, Reinberg D, Bird A (1999) MBD2 is a transcriptional repressor belonging to MeCP1 histone deacetylase complex. Nat Genet 23:58–61
    CAS PubMed Google Scholar
  63. Colantuoni C, Jeon E, Hyder K, Chenchik A, Khimani AH, Narayanan V, Hoffman EP, Kaufmann WE, Naidu S, Pevsner J (2001) Gene expression profiling in postmortem Rett syndrome brain: differential gene expression and patient classification. Neurobiol Dis 8:847–865
    Article CAS PubMed Google Scholar
  64. Deguchi K, Antalffy BA, Twohill LJ, Chakraborty S, Glaze DG, Armstrong DD (2000) Substance P immunoreactivity in Rett syndrome. Pediatr Neurol 22:259–266
    Article CAS PubMed Google Scholar
  65. Johnston M, Jeon O, Pevsner J, Blue M, Naidu S (2001) Neurobiology of Rett syndrome: a genetic disorder of synapse development. Brain Dev [Suppl 1]:S206–S213
  66. Armstrong D, et al (1995) Selective dendritic alterations in the cortex of Rett syndrome. Neuropathol Exp Neurol 54:195–201
    CAS Google Scholar
  67. Tudor M, Akbarian S, Chen R, Jaenisch R (2002) Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in the brain. Proc Natl Acad Sci USA 99:15536–15541
    Article CAS Google Scholar
  68. Traynor J, Agarwal JP, Lazzeroni L, Francke U (2002) Gene expression patterns vary in clonal cell cultures from Rett syndrome females with eight different MECP2 mutations. BMC Med Genet 3:12
    Article PubMed Google Scholar
  69. Balmer D, Arredondo J, Samaco RC, LaSalle JM (2002) MECP2 mutations in Rett syndrome adversely affect lymphocyte growth, but do not affect imprinted gene expression in blood or brain. Hum Genet 110:545–552
    Article CAS PubMed Google Scholar

Download references